Dr. Martens plc (LON:DOCS – Get Free Report) insider Kenny Wilson bought 199 shares of the business’s stock in a transaction on Wednesday, December 11th. The stock was purchased at an average price of GBX 76 ($0.96) per share, for a total transaction of £151.24 ($190.96).
Kenny Wilson also recently made the following trade(s):
- On Thursday, September 26th, Kenny Wilson purchased 30,000 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 55 ($0.69) per share, with a total value of £16,500 ($20,833.33).
Dr. Martens Stock Performance
DOCS stock opened at GBX 76.55 ($0.97) on Monday. Dr. Martens plc has a 1-year low of GBX 49.32 ($0.62) and a 1-year high of GBX 100 ($1.26). The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 129.55. The firm has a market cap of £736.20 million, a PE ratio of 1,093.57, a P/E/G ratio of 6.40 and a beta of 0.11. The business’s 50-day moving average price is GBX 59.81 and its two-hundred day moving average price is GBX 67.25.
Dr. Martens Cuts Dividend
About Dr. Martens
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Dr. Martens
- How to Find Undervalued Stocks
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Are Dividend Achievers? An Introduction
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.